TCL Archive In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post April 1, 1994
TCL Archive Prostate Cancer Patient Groups Consider formation Of Coalition Using the “NBCC Model” August 16, 1996
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
